Additional file 1. MLPA results and clinical follow-up data. The clinicopathological characteristics, clinical follow-up data and MLPA results are showed in this file.
A novel structural series of quinoline derivatives were designed, synthesized and biologically evaluated as PI3K/mTOR dual inhibitors upon incorporation of C-4 acrylamide fragment. Consequently, all o
Distribution of class labels and subtypes for the 892 samples with a proper class label. and denote the number of negative (good prognosis) and positive (poor prognosis) cases of for each subtype ,
